Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

    Home > Events > Veristat to appear at the 2017 asco annual meeting

    1 min read

    Veristat to Appear at the 2017 ASCO Annual Meeting

    am2017-mobile-banner-text.pngJoin Veristat at the 2017 ASCO Annual Meeting, the world’s largest annual gathering of oncology healthcare and clinical research professionals taking place from June 2-6, 2017 in Chicago, IL.   It is anticipated that more than 38,000 attendees will convene this year to achieve the conference theme of “Making a Difference in Cancer Care WITH YOU”

    Meet with the Veristat Team at ASCO

    Veristat will be sending a team of our oncology clinical trial experts to ASCO this year,  including:

     

    Email Headshot_Jim Roach.pngJim Roach

    Chief Medical Officer

     

     

     

     

     

    Email Headshot_Theresa Bruce.pngTheresa Bruce 

    Vice President

    Clinical Operations

     

     

     

     

    Email Headshot_Cindy Henderson.pngCindy Henderson

    Executive Vice President of
    Strategic Development

     

     

     

     

     

    Schedule a Meeting

    Meet up with Veristat while you are at ASCO.  Veristat’s experienced teams have helped clients run over 335 Oncology studies for solid tumors, hematologic malignancies and more.  Additionally, we’ve worked on over 20 US and European regulatory submission projects for cancer treatments, including many rare cancers.

     Schedule a time to speak with Veristat at ASCO on how we can put our oncology clinical trial and regulatory submission experience to work for you.   Fill out the form on the right.

     

    Share This Event:

       

    11 min read

    Monthly FDA Guidance and Regulatory News Review - September 2026

    This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...

    8 min read

    Monthly FDA Guidance and Regulatory News Review - August 2026

    This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...